nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Ezetimibe—coronary artery disease	0.126	0.226	CbGbCtD
Raltegravir—UGT1A1—Simvastatin—coronary artery disease	0.117	0.21	CbGbCtD
Raltegravir—UGT1A1—Lovastatin—coronary artery disease	0.114	0.206	CbGbCtD
Raltegravir—UGT1A1—Atorvastatin—coronary artery disease	0.104	0.187	CbGbCtD
Raltegravir—UGT1A1—Losartan—coronary artery disease	0.0953	0.171	CbGbCtD
Raltegravir—CCR1—myocardium—coronary artery disease	0.00422	0.323	CbGeAlD
Raltegravir—CCR1—heart—coronary artery disease	0.00294	0.226	CbGeAlD
Raltegravir—CCR1—cardiovascular system—coronary artery disease	0.00278	0.213	CbGeAlD
Raltegravir—CCR1—blood—coronary artery disease	0.0022	0.168	CbGeAlD
Raltegravir—UGT1A1—blood—coronary artery disease	0.000903	0.0692	CbGeAlD
Raltegravir—CCR1—Signaling Pathways—CASR—coronary artery disease	0.000102	0.000649	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—ADRB2—coronary artery disease	0.000101	0.00064	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—BDKRB1—coronary artery disease	0.0001	0.000636	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—P4HB—coronary artery disease	0.0001	0.000636	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GNA12—coronary artery disease	0.0001	0.000636	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CX3CL1—coronary artery disease	0.0001	0.000636	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PRKCE—coronary artery disease	9.94e-05	0.000632	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—EDN1—coronary artery disease	9.91e-05	0.00063	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCL5—coronary artery disease	9.83e-05	0.000625	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PPP3R1—coronary artery disease	9.82e-05	0.000625	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ADM—coronary artery disease	9.73e-05	0.000619	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CSF2—coronary artery disease	9.69e-05	0.000616	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—GSTP1—coronary artery disease	9.51e-05	0.000604	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—TGFBR2—coronary artery disease	9.51e-05	0.000604	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PDE4B—coronary artery disease	9.48e-05	0.000603	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CYBB—coronary artery disease	9.48e-05	0.000603	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CXCL8—coronary artery disease	9.48e-05	0.000603	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—MMP3—coronary artery disease	9.46e-05	0.000602	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—HMOX1—coronary artery disease	9.37e-05	0.000596	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—GGT1—coronary artery disease	9.28e-05	0.00059	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—EDN1—coronary artery disease	9e-05	0.000572	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—coronary artery disease	8.97e-05	0.00057	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCL5—coronary artery disease	8.93e-05	0.000568	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PRKCD—coronary artery disease	8.86e-05	0.000563	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CSF2—coronary artery disease	8.8e-05	0.000559	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—HGF—coronary artery disease	8.73e-05	0.000555	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—GSTM1—coronary artery disease	8.73e-05	0.000555	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCR3—coronary artery disease	8.67e-05	0.000552	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—HTR2A—coronary artery disease	8.67e-05	0.000551	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—C3—coronary artery disease	8.66e-05	0.000551	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CRK—coronary artery disease	8.56e-05	0.000544	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ATP2A2—coronary artery disease	8.45e-05	0.000538	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—VWF—coronary artery disease	8.45e-05	0.000538	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SH2B3—coronary artery disease	8.45e-05	0.000538	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CA5B—coronary artery disease	8.43e-05	0.000536	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—AGER—coronary artery disease	8.42e-05	0.000536	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—APOC3—coronary artery disease	8.4e-05	0.000534	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—coronary artery disease	8.38e-05	0.000533	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—LDLR—coronary artery disease	8.35e-05	0.000531	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—GSTP1—coronary artery disease	8.34e-05	0.00053	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AGT—coronary artery disease	8.23e-05	0.000523	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—GSTP1—coronary artery disease	8.22e-05	0.000523	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PPP2CA—coronary artery disease	8.19e-05	0.000521	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCL3—coronary artery disease	8.16e-05	0.000519	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CXCL2—coronary artery disease	8.16e-05	0.000519	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SDC1—coronary artery disease	8.06e-05	0.000513	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—F2R—coronary artery disease	8.06e-05	0.000513	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PRKCD—coronary artery disease	8.05e-05	0.000512	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—FGB—coronary artery disease	7.89e-05	0.000502	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—HTR2A—coronary artery disease	7.87e-05	0.000501	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—C3—coronary artery disease	7.86e-05	0.0005	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—EDNRB—coronary artery disease	7.81e-05	0.000497	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—THBS1—coronary artery disease	7.69e-05	0.000489	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—GSTM1—coronary artery disease	7.66e-05	0.000487	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PSMB5—coronary artery disease	7.62e-05	0.000484	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PSMA6—coronary artery disease	7.62e-05	0.000484	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—F2—coronary artery disease	7.6e-05	0.000483	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—GSTM1—coronary artery disease	7.56e-05	0.000481	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AGT—coronary artery disease	7.47e-05	0.000475	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—EDNRA—coronary artery disease	7.38e-05	0.000469	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ADRB1—coronary artery disease	7.34e-05	0.000467	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CYBA—coronary artery disease	7.34e-05	0.000467	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—DUSP6—coronary artery disease	7.31e-05	0.000465	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PLAT—coronary artery disease	7.19e-05	0.000457	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CKMT1B—coronary artery disease	7.17e-05	0.000456	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CXCL12—coronary artery disease	6.93e-05	0.000441	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—BDKRB2—coronary artery disease	6.93e-05	0.000441	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—POMC—coronary artery disease	6.92e-05	0.00044	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—F2—coronary artery disease	6.9e-05	0.000439	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL6ST—coronary artery disease	6.88e-05	0.000437	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—JUNB—coronary artery disease	6.81e-05	0.000433	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PLCB1—coronary artery disease	6.78e-05	0.000431	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HTR7—coronary artery disease	6.64e-05	0.000422	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ITGAV—coronary artery disease	6.33e-05	0.000402	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—KNG1—coronary artery disease	6.31e-05	0.000401	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—POMC—coronary artery disease	6.29e-05	0.0004	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CREB1—coronary artery disease	6.29e-05	0.0004	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AGTR1—coronary artery disease	6.27e-05	0.000399	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCL2—coronary artery disease	6.15e-05	0.000391	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL6R—coronary artery disease	6.13e-05	0.00039	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CXCL10—coronary artery disease	6.13e-05	0.00039	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PLG—coronary artery disease	6.11e-05	0.000389	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ADRB2—coronary artery disease	5.95e-05	0.000378	CbGpPWpGaD
Raltegravir—Headache—Lovastatin—coronary artery disease	5.9e-05	0.000216	CcSEcCtD
Raltegravir—Pruritus—Valsartan—coronary artery disease	5.89e-05	0.000216	CcSEcCtD
Raltegravir—Dry mouth—Ramipril—coronary artery disease	5.89e-05	0.000216	CcSEcCtD
Raltegravir—Myalgia—Timolol—coronary artery disease	5.88e-05	0.000215	CcSEcCtD
Raltegravir—Chest pain—Timolol—coronary artery disease	5.88e-05	0.000215	CcSEcCtD
Raltegravir—Arthralgia—Timolol—coronary artery disease	5.88e-05	0.000215	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—PRKCE—coronary artery disease	5.87e-05	0.000374	CbGpPWpGaD
Raltegravir—Vomiting—Ezetimibe—coronary artery disease	5.87e-05	0.000215	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—JAK2—coronary artery disease	5.87e-05	0.000373	CbGpPWpGaD
Raltegravir—Hypersensitivity—Pravastatin—coronary artery disease	5.87e-05	0.000215	CcSEcCtD
Raltegravir—Gastrointestinal pain—Perindopril—coronary artery disease	5.87e-05	0.000215	CcSEcCtD
Raltegravir—Anxiety—Timolol—coronary artery disease	5.86e-05	0.000215	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—SOCS1—coronary artery disease	5.86e-05	0.000373	CbGpPWpGaD
Raltegravir—Pruritus—Olmesartan—coronary artery disease	5.86e-05	0.000215	CcSEcCtD
Raltegravir—Decreased appetite—Losartan—coronary artery disease	5.85e-05	0.000214	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—S100B—coronary artery disease	5.84e-05	0.000372	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CKM—coronary artery disease	5.84e-05	0.000372	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—UQCRFS1—coronary artery disease	5.84e-05	0.000372	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPAP2B—coronary artery disease	5.84e-05	0.000372	CbGpPWpGaD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	5.84e-05	0.000214	CcSEcCtD
Raltegravir—Body temperature increased—Captopril—coronary artery disease	5.84e-05	0.000214	CcSEcCtD
Raltegravir—Abdominal pain—Captopril—coronary artery disease	5.84e-05	0.000214	CcSEcCtD
Raltegravir—Dizziness—Simvastatin—coronary artery disease	5.83e-05	0.000213	CcSEcCtD
Raltegravir—Rash—Ezetimibe—coronary artery disease	5.82e-05	0.000213	CcSEcCtD
Raltegravir—Dermatitis—Ezetimibe—coronary artery disease	5.82e-05	0.000213	CcSEcCtD
Raltegravir—Confusional state—Ramipril—coronary artery disease	5.82e-05	0.000213	CcSEcCtD
Raltegravir—Discomfort—Timolol—coronary artery disease	5.81e-05	0.000213	CcSEcCtD
Raltegravir—Asthenia—Niacin—coronary artery disease	5.8e-05	0.000213	CcSEcCtD
Raltegravir—Fatigue—Losartan—coronary artery disease	5.8e-05	0.000212	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—SOCS3—coronary artery disease	5.79e-05	0.000368	CbGpPWpGaD
Raltegravir—Headache—Ezetimibe—coronary artery disease	5.79e-05	0.000212	CcSEcCtD
Raltegravir—Malaise—Lisinopril—coronary artery disease	5.78e-05	0.000212	CcSEcCtD
Raltegravir—Vertigo—Lisinopril—coronary artery disease	5.76e-05	0.000211	CcSEcCtD
Raltegravir—Dry mouth—Timolol—coronary artery disease	5.75e-05	0.000211	CcSEcCtD
Raltegravir—Constipation—Losartan—coronary artery disease	5.75e-05	0.000211	CcSEcCtD
Raltegravir—Pain—Losartan—coronary artery disease	5.75e-05	0.000211	CcSEcCtD
Raltegravir—Vomiting—Eplerenone—coronary artery disease	5.75e-05	0.000211	CcSEcCtD
Raltegravir—Feeling abnormal—Furosemide—coronary artery disease	5.75e-05	0.00021	CcSEcCtD
Raltegravir—Nausea—Fenofibrate—coronary artery disease	5.73e-05	0.00021	CcSEcCtD
Raltegravir—Pruritus—Niacin—coronary artery disease	5.72e-05	0.00021	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—TGFBR2—coronary artery disease	5.72e-05	0.000364	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—KITLG—coronary artery disease	5.72e-05	0.000364	CbGpPWpGaD
Raltegravir—Asthenia—Pravastatin—coronary artery disease	5.71e-05	0.000209	CcSEcCtD
Raltegravir—Gastrointestinal pain—Furosemide—coronary artery disease	5.7e-05	0.000209	CcSEcCtD
Raltegravir—Rash—Eplerenone—coronary artery disease	5.7e-05	0.000209	CcSEcCtD
Raltegravir—Urticaria—Perindopril—coronary artery disease	5.7e-05	0.000209	CcSEcCtD
Raltegravir—Hypersensitivity—Trandolapril—coronary artery disease	5.7e-05	0.000209	CcSEcCtD
Raltegravir—Dermatitis—Eplerenone—coronary artery disease	5.7e-05	0.000209	CcSEcCtD
Raltegravir—Diarrhoea—Valsartan—coronary artery disease	5.69e-05	0.000208	CcSEcCtD
Raltegravir—Confusional state—Timolol—coronary artery disease	5.69e-05	0.000208	CcSEcCtD
Raltegravir—Hypersensitivity—Enalapril—coronary artery disease	5.68e-05	0.000208	CcSEcCtD
Raltegravir—Body temperature increased—Perindopril—coronary artery disease	5.67e-05	0.000208	CcSEcCtD
Raltegravir—Abdominal pain—Perindopril—coronary artery disease	5.67e-05	0.000208	CcSEcCtD
Raltegravir—Palpitations—Lisinopril—coronary artery disease	5.67e-05	0.000207	CcSEcCtD
Raltegravir—Diarrhoea—Olmesartan—coronary artery disease	5.66e-05	0.000207	CcSEcCtD
Raltegravir—Headache—Eplerenone—coronary artery disease	5.66e-05	0.000207	CcSEcCtD
Raltegravir—Nervous system disorder—Ramipril—coronary artery disease	5.66e-05	0.000207	CcSEcCtD
Raltegravir—Thrombocytopenia—Ramipril—coronary artery disease	5.65e-05	0.000207	CcSEcCtD
Raltegravir—Pruritus—Pravastatin—coronary artery disease	5.63e-05	0.000206	CcSEcCtD
Raltegravir—Nausea—Clopidogrel—coronary artery disease	5.63e-05	0.000206	CcSEcCtD
Raltegravir—Skin disorder—Ramipril—coronary artery disease	5.6e-05	0.000205	CcSEcCtD
Raltegravir—Infection—Timolol—coronary artery disease	5.6e-05	0.000205	CcSEcCtD
Raltegravir—Vomiting—Simvastatin—coronary artery disease	5.6e-05	0.000205	CcSEcCtD
Raltegravir—Hypersensitivity—Telmisartan—coronary artery disease	5.6e-05	0.000205	CcSEcCtD
Raltegravir—Cough—Lisinopril—coronary artery disease	5.59e-05	0.000205	CcSEcCtD
Raltegravir—Nausea—Lovastatin—coronary artery disease	5.59e-05	0.000205	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—MMP3—coronary artery disease	5.59e-05	0.000355	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—STAT5A—coronary artery disease	5.59e-05	0.000355	CbGpPWpGaD
Raltegravir—Hyperhidrosis—Ramipril—coronary artery disease	5.58e-05	0.000204	CcSEcCtD
Raltegravir—Rash—Simvastatin—coronary artery disease	5.55e-05	0.000203	CcSEcCtD
Raltegravir—Dermatitis—Simvastatin—coronary artery disease	5.55e-05	0.000203	CcSEcCtD
Raltegravir—Asthenia—Trandolapril—coronary artery disease	5.55e-05	0.000203	CcSEcCtD
Raltegravir—Feeling abnormal—Losartan—coronary artery disease	5.54e-05	0.000203	CcSEcCtD
Raltegravir—Urticaria—Furosemide—coronary artery disease	5.54e-05	0.000203	CcSEcCtD
Raltegravir—Diarrhoea—Niacin—coronary artery disease	5.53e-05	0.000203	CcSEcCtD
Raltegravir—Nervous system disorder—Timolol—coronary artery disease	5.53e-05	0.000203	CcSEcCtD
Raltegravir—Asthenia—Enalapril—coronary artery disease	5.53e-05	0.000202	CcSEcCtD
Raltegravir—Headache—Simvastatin—coronary artery disease	5.52e-05	0.000202	CcSEcCtD
Raltegravir—Abdominal pain—Furosemide—coronary artery disease	5.51e-05	0.000202	CcSEcCtD
Raltegravir—Body temperature increased—Furosemide—coronary artery disease	5.51e-05	0.000202	CcSEcCtD
Raltegravir—Gastrointestinal pain—Losartan—coronary artery disease	5.5e-05	0.000202	CcSEcCtD
Raltegravir—Dizziness—Valsartan—coronary artery disease	5.5e-05	0.000201	CcSEcCtD
Raltegravir—Nausea—Ezetimibe—coronary artery disease	5.49e-05	0.000201	CcSEcCtD
Raltegravir—Skin disorder—Timolol—coronary artery disease	5.48e-05	0.000201	CcSEcCtD
Raltegravir—Dizziness—Olmesartan—coronary artery disease	5.47e-05	0.000201	CcSEcCtD
Raltegravir—Pruritus—Trandolapril—coronary artery disease	5.47e-05	0.0002	CcSEcCtD
Raltegravir—Myalgia—Lisinopril—coronary artery disease	5.46e-05	0.0002	CcSEcCtD
Raltegravir—Arthralgia—Lisinopril—coronary artery disease	5.46e-05	0.0002	CcSEcCtD
Raltegravir—Chest pain—Lisinopril—coronary artery disease	5.46e-05	0.0002	CcSEcCtD
Raltegravir—Hyperhidrosis—Timolol—coronary artery disease	5.45e-05	0.0002	CcSEcCtD
Raltegravir—Asthenia—Telmisartan—coronary artery disease	5.45e-05	0.0002	CcSEcCtD
Raltegravir—Pruritus—Enalapril—coronary artery disease	5.45e-05	0.0002	CcSEcCtD
Raltegravir—Diarrhoea—Pravastatin—coronary artery disease	5.45e-05	0.0002	CcSEcCtD
Raltegravir—Anxiety—Lisinopril—coronary artery disease	5.44e-05	0.000199	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—CKMT2—coronary artery disease	5.43e-05	0.000345	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PDK4—coronary artery disease	5.43e-05	0.000345	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SULT4A1—coronary artery disease	5.43e-05	0.000345	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PYGM—coronary artery disease	5.43e-05	0.000345	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALDH6A1—coronary artery disease	5.43e-05	0.000345	CbGpPWpGaD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	5.42e-05	0.000199	CcSEcCtD
Raltegravir—UGT1A1—Biological oxidations—POMC—coronary artery disease	5.42e-05	0.000344	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—APOB—coronary artery disease	5.4e-05	0.000344	CbGpPWpGaD
Raltegravir—Discomfort—Lisinopril—coronary artery disease	5.39e-05	0.000198	CcSEcCtD
Raltegravir—Pruritus—Telmisartan—coronary artery disease	5.38e-05	0.000197	CcSEcCtD
Raltegravir—Nausea—Eplerenone—coronary artery disease	5.37e-05	0.000197	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—CXCL8—coronary artery disease	5.36e-05	0.000341	CbGpPWpGaD
Raltegravir—Dizziness—Niacin—coronary artery disease	5.35e-05	0.000196	CcSEcCtD
Raltegravir—Urticaria—Losartan—coronary artery disease	5.34e-05	0.000196	CcSEcCtD
Raltegravir—Dry mouth—Lisinopril—coronary artery disease	5.34e-05	0.000196	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—JAK2—coronary artery disease	5.33e-05	0.000339	CbGpPWpGaD
Raltegravir—Abdominal pain—Losartan—coronary artery disease	5.32e-05	0.000195	CcSEcCtD
Raltegravir—Body temperature increased—Losartan—coronary artery disease	5.32e-05	0.000195	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—EDN1—coronary artery disease	5.32e-05	0.000338	CbGpPWpGaD
Raltegravir—Asthenia—Captopril—coronary artery disease	5.3e-05	0.000194	CcSEcCtD
Raltegravir—Diarrhoea—Trandolapril—coronary artery disease	5.29e-05	0.000194	CcSEcCtD
Raltegravir—Vomiting—Valsartan—coronary artery disease	5.29e-05	0.000194	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CCL5—coronary artery disease	5.28e-05	0.000335	CbGpPWpGaD
Raltegravir—Confusional state—Lisinopril—coronary artery disease	5.28e-05	0.000193	CcSEcCtD
Raltegravir—Diarrhoea—Enalapril—coronary artery disease	5.27e-05	0.000193	CcSEcCtD
Raltegravir—Dizziness—Pravastatin—coronary artery disease	5.27e-05	0.000193	CcSEcCtD
Raltegravir—Vomiting—Olmesartan—coronary artery disease	5.26e-05	0.000193	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.26e-05	0.000193	CcSEcCtD
Raltegravir—Rash—Valsartan—coronary artery disease	5.25e-05	0.000192	CcSEcCtD
Raltegravir—Dermatitis—Valsartan—coronary artery disease	5.24e-05	0.000192	CcSEcCtD
Raltegravir—Nausea—Simvastatin—coronary artery disease	5.23e-05	0.000192	CcSEcCtD
Raltegravir—Pruritus—Captopril—coronary artery disease	5.23e-05	0.000191	CcSEcCtD
Raltegravir—Rash—Olmesartan—coronary artery disease	5.22e-05	0.000191	CcSEcCtD
Raltegravir—Insomnia—Ramipril—coronary artery disease	5.22e-05	0.000191	CcSEcCtD
Raltegravir—Dermatitis—Olmesartan—coronary artery disease	5.22e-05	0.000191	CcSEcCtD
Raltegravir—Headache—Valsartan—coronary artery disease	5.21e-05	0.000191	CcSEcCtD
Raltegravir—Diarrhoea—Telmisartan—coronary artery disease	5.2e-05	0.00019	CcSEcCtD
Raltegravir—Infection—Lisinopril—coronary artery disease	5.2e-05	0.00019	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—FGF1—coronary artery disease	5.2e-05	0.00033	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CSF2—coronary artery disease	5.2e-05	0.00033	CbGpPWpGaD
Raltegravir—Headache—Olmesartan—coronary artery disease	5.19e-05	0.00019	CcSEcCtD
Raltegravir—Paraesthesia—Ramipril—coronary artery disease	5.18e-05	0.00019	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—LPL—coronary artery disease	5.16e-05	0.000328	CbGpPWpGaD
Raltegravir—Asthenia—Perindopril—coronary artery disease	5.15e-05	0.000188	CcSEcCtD
Raltegravir—Vomiting—Niacin—coronary artery disease	5.14e-05	0.000188	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Timolol—coronary artery disease	5.14e-05	0.000188	CcSEcCtD
Raltegravir—Hypersensitivity—Furosemide—coronary artery disease	5.14e-05	0.000188	CcSEcCtD
Raltegravir—Somnolence—Ramipril—coronary artery disease	5.13e-05	0.000188	CcSEcCtD
Raltegravir—Thrombocytopenia—Lisinopril—coronary artery disease	5.12e-05	0.000188	CcSEcCtD
Raltegravir—Dizziness—Trandolapril—coronary artery disease	5.11e-05	0.000187	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—RPS6KB1—coronary artery disease	5.11e-05	0.000325	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MEF2C—coronary artery disease	5.11e-05	0.000325	CbGpPWpGaD
Raltegravir—Insomnia—Timolol—coronary artery disease	5.1e-05	0.000187	CcSEcCtD
Raltegravir—Rash—Niacin—coronary artery disease	5.1e-05	0.000187	CcSEcCtD
Raltegravir—Dermatitis—Niacin—coronary artery disease	5.1e-05	0.000187	CcSEcCtD
Raltegravir—Dizziness—Enalapril—coronary artery disease	5.09e-05	0.000187	CcSEcCtD
Raltegravir—Skin disorder—Lisinopril—coronary artery disease	5.08e-05	0.000186	CcSEcCtD
Raltegravir—Dyspepsia—Ramipril—coronary artery disease	5.08e-05	0.000186	CcSEcCtD
Raltegravir—Pruritus—Perindopril—coronary artery disease	5.07e-05	0.000186	CcSEcCtD
Raltegravir—Headache—Niacin—coronary artery disease	5.07e-05	0.000186	CcSEcCtD
Raltegravir—Paraesthesia—Timolol—coronary artery disease	5.06e-05	0.000185	CcSEcCtD
Raltegravir—Vomiting—Pravastatin—coronary artery disease	5.06e-05	0.000185	CcSEcCtD
Raltegravir—Hyperhidrosis—Lisinopril—coronary artery disease	5.06e-05	0.000185	CcSEcCtD
Raltegravir—Diarrhoea—Captopril—coronary artery disease	5.05e-05	0.000185	CcSEcCtD
Raltegravir—Dizziness—Telmisartan—coronary artery disease	5.02e-05	0.000184	CcSEcCtD
Raltegravir—Rash—Pravastatin—coronary artery disease	5.02e-05	0.000184	CcSEcCtD
Raltegravir—Dermatitis—Pravastatin—coronary artery disease	5.02e-05	0.000184	CcSEcCtD
Raltegravir—Decreased appetite—Ramipril—coronary artery disease	5.01e-05	0.000184	CcSEcCtD
Raltegravir—Somnolence—Timolol—coronary artery disease	5.01e-05	0.000184	CcSEcCtD
Raltegravir—Asthenia—Furosemide—coronary artery disease	5e-05	0.000183	CcSEcCtD
Raltegravir—Headache—Pravastatin—coronary artery disease	4.99e-05	0.000183	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—ITGB3—coronary artery disease	4.98e-05	0.000317	CbGpPWpGaD
Raltegravir—Gastrointestinal disorder—Ramipril—coronary artery disease	4.98e-05	0.000182	CcSEcCtD
Raltegravir—Fatigue—Ramipril—coronary artery disease	4.97e-05	0.000182	CcSEcCtD
Raltegravir—Dyspepsia—Timolol—coronary artery disease	4.96e-05	0.000182	CcSEcCtD
Raltegravir—Hypersensitivity—Losartan—coronary artery disease	4.96e-05	0.000182	CcSEcCtD
Raltegravir—Nausea—Valsartan—coronary artery disease	4.94e-05	0.000181	CcSEcCtD
Raltegravir—Pruritus—Furosemide—coronary artery disease	4.93e-05	0.000181	CcSEcCtD
Raltegravir—Constipation—Ramipril—coronary artery disease	4.93e-05	0.000181	CcSEcCtD
Raltegravir—Nausea—Olmesartan—coronary artery disease	4.92e-05	0.00018	CcSEcCtD
Raltegravir—Vomiting—Trandolapril—coronary artery disease	4.92e-05	0.00018	CcSEcCtD
Raltegravir—Diarrhoea—Perindopril—coronary artery disease	4.91e-05	0.00018	CcSEcCtD
Raltegravir—Decreased appetite—Timolol—coronary artery disease	4.9e-05	0.00018	CcSEcCtD
Raltegravir—Vomiting—Enalapril—coronary artery disease	4.9e-05	0.000179	CcSEcCtD
Raltegravir—Dizziness—Captopril—coronary artery disease	4.89e-05	0.000179	CcSEcCtD
Raltegravir—Rash—Trandolapril—coronary artery disease	4.88e-05	0.000179	CcSEcCtD
Raltegravir—Dermatitis—Trandolapril—coronary artery disease	4.87e-05	0.000178	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Timolol—coronary artery disease	4.87e-05	0.000178	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—CXCL8—coronary artery disease	4.86e-05	0.000309	CbGpPWpGaD
Raltegravir—Fatigue—Timolol—coronary artery disease	4.86e-05	0.000178	CcSEcCtD
Raltegravir—Rash—Enalapril—coronary artery disease	4.86e-05	0.000178	CcSEcCtD
Raltegravir—Dermatitis—Enalapril—coronary artery disease	4.85e-05	0.000178	CcSEcCtD
Raltegravir—Headache—Trandolapril—coronary artery disease	4.84e-05	0.000177	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—HMGCS2—coronary artery disease	4.84e-05	0.000308	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PFKM—coronary artery disease	4.84e-05	0.000308	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GYG1—coronary artery disease	4.84e-05	0.000308	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GK—coronary artery disease	4.84e-05	0.000308	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LDHA—coronary artery disease	4.84e-05	0.000308	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GATM—coronary artery disease	4.84e-05	0.000308	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PPP2CA—coronary artery disease	4.84e-05	0.000308	CbGpPWpGaD
Raltegravir—Vomiting—Telmisartan—coronary artery disease	4.83e-05	0.000177	CcSEcCtD
Raltegravir—Asthenia—Losartan—coronary artery disease	4.83e-05	0.000177	CcSEcCtD
Raltegravir—Headache—Enalapril—coronary artery disease	4.83e-05	0.000177	CcSEcCtD
Raltegravir—Pain—Timolol—coronary artery disease	4.82e-05	0.000177	CcSEcCtD
Raltegravir—Nausea—Niacin—coronary artery disease	4.8e-05	0.000176	CcSEcCtD
Raltegravir—Rash—Telmisartan—coronary artery disease	4.79e-05	0.000175	CcSEcCtD
Raltegravir—Dermatitis—Telmisartan—coronary artery disease	4.79e-05	0.000175	CcSEcCtD
Raltegravir—Diarrhoea—Furosemide—coronary artery disease	4.77e-05	0.000175	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Lisinopril—coronary artery disease	4.77e-05	0.000175	CcSEcCtD
Raltegravir—Pruritus—Losartan—coronary artery disease	4.76e-05	0.000174	CcSEcCtD
Raltegravir—Headache—Telmisartan—coronary artery disease	4.76e-05	0.000174	CcSEcCtD
Raltegravir—Feeling abnormal—Ramipril—coronary artery disease	4.75e-05	0.000174	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—PRKCD—coronary artery disease	4.75e-05	0.000302	CbGpPWpGaD
Raltegravir—Dizziness—Perindopril—coronary artery disease	4.74e-05	0.000174	CcSEcCtD
Raltegravir—Insomnia—Lisinopril—coronary artery disease	4.73e-05	0.000173	CcSEcCtD
Raltegravir—Nausea—Pravastatin—coronary artery disease	4.73e-05	0.000173	CcSEcCtD
Raltegravir—Gastrointestinal pain—Ramipril—coronary artery disease	4.72e-05	0.000173	CcSEcCtD
Raltegravir—Paraesthesia—Lisinopril—coronary artery disease	4.7e-05	0.000172	CcSEcCtD
Raltegravir—Vomiting—Captopril—coronary artery disease	4.7e-05	0.000172	CcSEcCtD
Raltegravir—Rash—Captopril—coronary artery disease	4.66e-05	0.000171	CcSEcCtD
Raltegravir—Dermatitis—Captopril—coronary artery disease	4.65e-05	0.00017	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—HTR2A—coronary artery disease	4.65e-05	0.000296	CbGpPWpGaD
Raltegravir—Somnolence—Lisinopril—coronary artery disease	4.65e-05	0.00017	CcSEcCtD
Raltegravir—Feeling abnormal—Timolol—coronary artery disease	4.65e-05	0.00017	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—C3—coronary artery disease	4.64e-05	0.000295	CbGpPWpGaD
Raltegravir—Headache—Captopril—coronary artery disease	4.63e-05	0.00017	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—AK1—coronary artery disease	4.62e-05	0.000294	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GCH1—coronary artery disease	4.62e-05	0.000294	CbGpPWpGaD
Raltegravir—Gastrointestinal pain—Timolol—coronary artery disease	4.61e-05	0.000169	CcSEcCtD
Raltegravir—Dizziness—Furosemide—coronary artery disease	4.61e-05	0.000169	CcSEcCtD
Raltegravir—Dyspepsia—Lisinopril—coronary artery disease	4.61e-05	0.000169	CcSEcCtD
Raltegravir—Diarrhoea—Losartan—coronary artery disease	4.6e-05	0.000169	CcSEcCtD
Raltegravir—Nausea—Trandolapril—coronary artery disease	4.59e-05	0.000168	CcSEcCtD
Raltegravir—Urticaria—Ramipril—coronary artery disease	4.58e-05	0.000168	CcSEcCtD
Raltegravir—Nausea—Enalapril—coronary artery disease	4.58e-05	0.000168	CcSEcCtD
Raltegravir—Vomiting—Perindopril—coronary artery disease	4.56e-05	0.000167	CcSEcCtD
Raltegravir—Abdominal pain—Ramipril—coronary artery disease	4.56e-05	0.000167	CcSEcCtD
Raltegravir—Body temperature increased—Ramipril—coronary artery disease	4.56e-05	0.000167	CcSEcCtD
Raltegravir—Decreased appetite—Lisinopril—coronary artery disease	4.55e-05	0.000167	CcSEcCtD
Raltegravir—Rash—Perindopril—coronary artery disease	4.52e-05	0.000166	CcSEcCtD
Raltegravir—Dermatitis—Perindopril—coronary artery disease	4.52e-05	0.000165	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.52e-05	0.000165	CcSEcCtD
Raltegravir—Nausea—Telmisartan—coronary artery disease	4.51e-05	0.000165	CcSEcCtD
Raltegravir—Fatigue—Lisinopril—coronary artery disease	4.51e-05	0.000165	CcSEcCtD
Raltegravir—Headache—Perindopril—coronary artery disease	4.49e-05	0.000165	CcSEcCtD
Raltegravir—Urticaria—Timolol—coronary artery disease	4.48e-05	0.000164	CcSEcCtD
Raltegravir—Pain—Lisinopril—coronary artery disease	4.47e-05	0.000164	CcSEcCtD
Raltegravir—Constipation—Lisinopril—coronary artery disease	4.47e-05	0.000164	CcSEcCtD
Raltegravir—Abdominal pain—Timolol—coronary artery disease	4.46e-05	0.000163	CcSEcCtD
Raltegravir—Body temperature increased—Timolol—coronary artery disease	4.46e-05	0.000163	CcSEcCtD
Raltegravir—Dizziness—Losartan—coronary artery disease	4.45e-05	0.000163	CcSEcCtD
Raltegravir—Vomiting—Furosemide—coronary artery disease	4.43e-05	0.000162	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—HIF1A—coronary artery disease	4.43e-05	0.000282	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—MDH2—coronary artery disease	4.43e-05	0.000282	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—UGCG—coronary artery disease	4.43e-05	0.000282	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PLCD1—coronary artery disease	4.43e-05	0.000282	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPAT—coronary artery disease	4.43e-05	0.000282	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AGT—coronary artery disease	4.41e-05	0.000281	CbGpPWpGaD
Raltegravir—Rash—Furosemide—coronary artery disease	4.4e-05	0.000161	CcSEcCtD
Raltegravir—Dermatitis—Furosemide—coronary artery disease	4.39e-05	0.000161	CcSEcCtD
Raltegravir—Nausea—Captopril—coronary artery disease	4.39e-05	0.000161	CcSEcCtD
Raltegravir—Headache—Furosemide—coronary artery disease	4.37e-05	0.00016	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—APOE—coronary artery disease	4.32e-05	0.000275	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—LEP—coronary artery disease	4.32e-05	0.000275	CbGpPWpGaD
Raltegravir—Feeling abnormal—Lisinopril—coronary artery disease	4.31e-05	0.000158	CcSEcCtD
Raltegravir—Gastrointestinal pain—Lisinopril—coronary artery disease	4.28e-05	0.000157	CcSEcCtD
Raltegravir—Vomiting—Losartan—coronary artery disease	4.28e-05	0.000157	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—APOA1—coronary artery disease	4.27e-05	0.000272	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PGM1—coronary artery disease	4.26e-05	0.000271	CbGpPWpGaD
Raltegravir—Nausea—Perindopril—coronary artery disease	4.26e-05	0.000156	CcSEcCtD
Raltegravir—Hypersensitivity—Ramipril—coronary artery disease	4.25e-05	0.000156	CcSEcCtD
Raltegravir—Rash—Losartan—coronary artery disease	4.24e-05	0.000155	CcSEcCtD
Raltegravir—Dermatitis—Losartan—coronary artery disease	4.24e-05	0.000155	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—KDR—coronary artery disease	4.24e-05	0.000269	CbGpPWpGaD
Raltegravir—Headache—Losartan—coronary artery disease	4.21e-05	0.000154	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—MAPK14—coronary artery disease	4.21e-05	0.000268	CbGpPWpGaD
Raltegravir—Urticaria—Lisinopril—coronary artery disease	4.16e-05	0.000152	CcSEcCtD
Raltegravir—Hypersensitivity—Timolol—coronary artery disease	4.16e-05	0.000152	CcSEcCtD
Raltegravir—Nausea—Furosemide—coronary artery disease	4.14e-05	0.000152	CcSEcCtD
Raltegravir—Asthenia—Ramipril—coronary artery disease	4.14e-05	0.000152	CcSEcCtD
Raltegravir—Abdominal pain—Lisinopril—coronary artery disease	4.14e-05	0.000151	CcSEcCtD
Raltegravir—Body temperature increased—Lisinopril—coronary artery disease	4.14e-05	0.000151	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—ESR1—coronary artery disease	4.13e-05	0.000263	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CKB—coronary artery disease	4.12e-05	0.000262	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PYGB—coronary artery disease	4.12e-05	0.000262	CbGpPWpGaD
Raltegravir—Pruritus—Ramipril—coronary artery disease	4.08e-05	0.000149	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—FN1—coronary artery disease	4.08e-05	0.000259	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—F2—coronary artery disease	4.08e-05	0.000259	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL6ST—coronary artery disease	4.06e-05	0.000258	CbGpPWpGaD
Raltegravir—Asthenia—Timolol—coronary artery disease	4.05e-05	0.000148	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—NFKBIA—coronary artery disease	4.03e-05	0.000256	CbGpPWpGaD
Raltegravir—Nausea—Losartan—coronary artery disease	4e-05	0.000146	CcSEcCtD
Raltegravir—Pruritus—Timolol—coronary artery disease	3.99e-05	0.000146	CcSEcCtD
Raltegravir—Diarrhoea—Ramipril—coronary artery disease	3.95e-05	0.000145	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—KIT—coronary artery disease	3.9e-05	0.000248	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—COX5B—coronary artery disease	3.87e-05	0.000246	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GSTM2—coronary artery disease	3.87e-05	0.000246	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PLIN1—coronary artery disease	3.87e-05	0.000246	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—DLAT—coronary artery disease	3.87e-05	0.000246	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PFKFB3—coronary artery disease	3.87e-05	0.000246	CbGpPWpGaD
Raltegravir—Diarrhoea—Timolol—coronary artery disease	3.86e-05	0.000141	CcSEcCtD
Raltegravir—Hypersensitivity—Lisinopril—coronary artery disease	3.85e-05	0.000141	CcSEcCtD
Raltegravir—Dizziness—Ramipril—coronary artery disease	3.81e-05	0.00014	CcSEcCtD
Raltegravir—Asthenia—Lisinopril—coronary artery disease	3.75e-05	0.000137	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—GSK3B—coronary artery disease	3.74e-05	0.000238	CbGpPWpGaD
Raltegravir—Dizziness—Timolol—coronary artery disease	3.73e-05	0.000137	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—POMC—coronary artery disease	3.71e-05	0.000236	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CREB1—coronary artery disease	3.71e-05	0.000236	CbGpPWpGaD
Raltegravir—Pruritus—Lisinopril—coronary artery disease	3.7e-05	0.000136	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—SULT1E1—coronary artery disease	3.67e-05	0.000233	CbGpPWpGaD
Raltegravir—Vomiting—Ramipril—coronary artery disease	3.67e-05	0.000134	CcSEcCtD
Raltegravir—Rash—Ramipril—coronary artery disease	3.64e-05	0.000133	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CCL2—coronary artery disease	3.63e-05	0.000231	CbGpPWpGaD
Raltegravir—Dermatitis—Ramipril—coronary artery disease	3.63e-05	0.000133	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—IL6R—coronary artery disease	3.62e-05	0.00023	CbGpPWpGaD
Raltegravir—Headache—Ramipril—coronary artery disease	3.61e-05	0.000132	CcSEcCtD
Raltegravir—Vomiting—Timolol—coronary artery disease	3.59e-05	0.000131	CcSEcCtD
Raltegravir—Diarrhoea—Lisinopril—coronary artery disease	3.58e-05	0.000131	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—IGF1—coronary artery disease	3.57e-05	0.000227	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—TGFB1—coronary artery disease	3.56e-05	0.000226	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—MAPK1—coronary artery disease	3.56e-05	0.000226	CbGpPWpGaD
Raltegravir—Rash—Timolol—coronary artery disease	3.56e-05	0.00013	CcSEcCtD
Raltegravir—Dermatitis—Timolol—coronary artery disease	3.55e-05	0.00013	CcSEcCtD
Raltegravir—Headache—Timolol—coronary artery disease	3.53e-05	0.000129	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—AKR1B1—coronary artery disease	3.5e-05	0.000223	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HK2—coronary artery disease	3.5e-05	0.000223	CbGpPWpGaD
Raltegravir—Dizziness—Lisinopril—coronary artery disease	3.46e-05	0.000127	CcSEcCtD
Raltegravir—Nausea—Ramipril—coronary artery disease	3.43e-05	0.000126	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—PIK3CA—coronary artery disease	3.4e-05	0.000216	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SERPINE1—coronary artery disease	3.39e-05	0.000216	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC27A1—coronary artery disease	3.36e-05	0.000213	CbGpPWpGaD
Raltegravir—Nausea—Timolol—coronary artery disease	3.35e-05	0.000123	CcSEcCtD
Raltegravir—Vomiting—Lisinopril—coronary artery disease	3.33e-05	0.000122	CcSEcCtD
Raltegravir—Rash—Lisinopril—coronary artery disease	3.3e-05	0.000121	CcSEcCtD
Raltegravir—Dermatitis—Lisinopril—coronary artery disease	3.3e-05	0.000121	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—LCAT—coronary artery disease	3.29e-05	0.000209	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CPT1B—coronary artery disease	3.29e-05	0.000209	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—FGF2—coronary artery disease	3.28e-05	0.000209	CbGpPWpGaD
Raltegravir—Headache—Lisinopril—coronary artery disease	3.28e-05	0.00012	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—NOS3—coronary artery disease	3.24e-05	0.000206	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOA4—coronary artery disease	3.23e-05	0.000205	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—JAK2—coronary artery disease	3.15e-05	0.0002	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GCLM—coronary artery disease	3.12e-05	0.000198	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PDHA1—coronary artery disease	3.12e-05	0.000198	CbGpPWpGaD
Raltegravir—Nausea—Lisinopril—coronary artery disease	3.11e-05	0.000114	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—PIK3CA—coronary artery disease	3.09e-05	0.000196	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP11B2—coronary artery disease	3.02e-05	0.000192	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—TXNRD1—coronary artery disease	3.02e-05	0.000192	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC22A3—coronary artery disease	2.98e-05	0.000189	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ARNTL—coronary artery disease	2.93e-05	0.000187	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HADH—coronary artery disease	2.93e-05	0.000187	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CXCL8—coronary artery disease	2.87e-05	0.000183	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOA2—coronary artery disease	2.78e-05	0.000177	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PLA2G2A—coronary artery disease	2.78e-05	0.000177	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GPX2—coronary artery disease	2.78e-05	0.000177	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AKT1—coronary artery disease	2.78e-05	0.000177	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CASP3—coronary artery disease	2.75e-05	0.000175	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ABCG5—coronary artery disease	2.75e-05	0.000175	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GPX4—coronary artery disease	2.75e-05	0.000175	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SULT1A1—coronary artery disease	2.75e-05	0.000175	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HK1—coronary artery disease	2.75e-05	0.000175	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL6—coronary artery disease	2.73e-05	0.000174	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HADHA—coronary artery disease	2.71e-05	0.000173	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GSTA1—coronary artery disease	2.68e-05	0.000171	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCND1—coronary artery disease	2.68e-05	0.00017	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LPA—coronary artery disease	2.65e-05	0.000169	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MMP9—coronary artery disease	2.6e-05	0.000165	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PLCB3—coronary artery disease	2.57e-05	0.000163	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOA5—coronary artery disease	2.54e-05	0.000162	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AKT1—coronary artery disease	2.52e-05	0.00016	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—P4HB—coronary artery disease	2.49e-05	0.000159	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PLA2G1B—coronary artery disease	2.45e-05	0.000156	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—VEGFA—coronary artery disease	2.33e-05	0.000148	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—VCAN—coronary artery disease	2.31e-05	0.000147	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALDOA—coronary artery disease	2.29e-05	0.000146	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—DCN—coronary artery disease	2.22e-05	0.000141	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALDH2—coronary artery disease	2.16e-05	0.000138	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TGFB1—coronary artery disease	2.14e-05	0.000136	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LIPC—coronary artery disease	2.11e-05	0.000134	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HBA1—coronary artery disease	2.11e-05	0.000134	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP2C19—coronary artery disease	2.11e-05	0.000134	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PIK3C2A—coronary artery disease	2.11e-05	0.000134	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MAPK1—coronary artery disease	2.1e-05	0.000134	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOC3—coronary artery disease	2.09e-05	0.000133	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LDLR—coronary artery disease	2.08e-05	0.000132	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC9A1—coronary artery disease	2.06e-05	0.000131	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GSTT1—coronary artery disease	2.06e-05	0.000131	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GCLC—coronary artery disease	2.03e-05	0.000129	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CETP—coronary artery disease	2.03e-05	0.000129	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SDC1—coronary artery disease	2.01e-05	0.000128	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PSMA6—coronary artery disease	1.9e-05	0.000121	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PSMB5—coronary artery disease	1.9e-05	0.000121	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CTGF—coronary artery disease	1.86e-05	0.000118	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HMGCR—coronary artery disease	1.84e-05	0.000117	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GOT2—coronary artery disease	1.84e-05	0.000117	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PIK3CA—coronary artery disease	1.82e-05	0.000116	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PLCB1—coronary artery disease	1.69e-05	0.000108	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ABCA1—coronary artery disease	1.64e-05	0.000104	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL6—coronary artery disease	1.61e-05	0.000103	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GOT1—coronary artery disease	1.59e-05	0.000101	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GGT1—coronary artery disease	1.59e-05	0.000101	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AKT1—coronary artery disease	1.49e-05	9.47e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GSTP1—coronary artery disease	1.43e-05	9.07e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARGC1A—coronary artery disease	1.41e-05	8.98e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HMOX1—coronary artery disease	1.41e-05	8.94e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CAT—coronary artery disease	1.39e-05	8.82e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOB—coronary artery disease	1.35e-05	8.57e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GSTM1—coronary artery disease	1.31e-05	8.33e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LPL—coronary artery disease	1.29e-05	8.18e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GPX1—coronary artery disease	1.25e-05	7.98e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CD36—coronary artery disease	1.22e-05	7.77e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPP2CA—coronary artery disease	1.21e-05	7.67e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—MTHFR—coronary artery disease	1.16e-05	7.36e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AGT—coronary artery disease	1.1e-05	7e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOE—coronary artery disease	1.08e-05	6.86e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOA1—coronary artery disease	1.07e-05	6.78e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARG—coronary artery disease	9.39e-06	5.97e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—POMC—coronary artery disease	9.26e-06	5.89e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALB—coronary artery disease	8.44e-06	5.37e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NOS3—coronary artery disease	8.08e-06	5.14e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PTGS2—coronary artery disease	7.39e-06	4.7e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PIK3CA—coronary artery disease	4.54e-06	2.89e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AKT1—coronary artery disease	3.71e-06	2.36e-05	CbGpPWpGaD
